Naskou et al. found a correlation between low EZH2 and high ATM expression in ovarian cancer cells responsive to chemotherapy [56].They proposed that low EZH2 expression favors ATM overactivity to confer G2-M block, checkpoint arrest and potential resistance to chemotherapy [56]. The gene discussed is EZH2; the disease is ovarian cancer.